General Range

GYNEXAPIL-21

Fortune LabsPanchkula, Haryana

Price on request/100 · MOQ 100 boxes

GYNEXAPIL-21 Tablets by Fortune Labs contain Levonorgestrel and Ethinylestradiol, a prescription combined oral contraceptive formulation used for pregnancy prevention. Levonorgestrel is a synthetic progestogen, while Ethinylestradiol is a synthetic estrogen. Together, they primarily suppress ovulation and alter cervical mucus to reduce the likelihood of pregnancy. GYNEXAPIL-21 may also help regulate menstrual bleeding and reduce period-related discomfort in selected patients when clinically appropriate. Available in convenient 21-tablet blister packaging with a printed carton box, the formulation provides a reversible hormonal contraceptive option for eligible women. GYNEXAPIL-21 should be taken according to a registered medical practitioner's instructions, considering medical history, cardiovascular risk factors, possible drug interactions, contraindications and correct contraceptive administration.

CategoryGeneral Range

Min. Order100 boxes

Supplied byFortune Labs

CertificationWHO-GMP, ISO

Prices are indicative and set by the listing company. Confirm net rates, packing and stock availability directly with the supplier.

View Company

Specifications

Composition: Levonorgestrel and Ethinylestradiol Tablets IP
Packaging Type: Tablet Blister Strip with Printed Carton Box
Packaging Size: 1 × 21 Tablets
Dosage Form: Tablet
Treatment: Helps prevent pregnancy when taken correctly according to prescribing instructions.
Shelf Life: 24 Months
Storage: Store below 30°C, protect from light & moisture
Certification: WHO-GMP, ISO

Company Info

Fortune LabsPanchkula, Haryana

View Full Profile

Fortune Labs is an Indian pharmaceutical and PCD (Propaganda Cum Distribution) pharma franchise company based in Panchkula, Haryana.

Key Details

• Headquarters: S.C.F 258, 1st Floor, Sector 16, Panchkula, Haryana, India
• Establishment: Founded in 2008 (sister concern of Prosperity 6 Pharmaceutics in Baddi)
• CEO / Leadership: Mayank Bansal
• Certifications: ISO 9001, WHO-GMP, and DCGI-approved formulations
• Business Model: Offers Pan-India PCD pharma franchises with monopoly rights, third-party manufacturing, and marketing support.

Product Portfolio & Therapeutic Ranges

• Formulations: Tablets, capsules, syrups, dry powders, injectables, ointments, gels, eye/ear/nasal drops, softgel capsules, and Ayurvedic/herbal products.
• Therapeutic Segments: Antibiotics, cardiac and diabetic care, orthopedics, dermatology, gynaecology, paediatrics, gastrointestinal/PPI ranges, neurology, antihistamines/cough-cold, and nutritional supplements.
Would you like information on how to apply for a franchise partnership or specific product price lists from Fortune Labs?